Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A ameloblastoma that involves the bone tissue.
Biomarker and diagnostic research for bone ameloblastoma has been reported in the published literature.
No clinical trials have been registered for bone ameloblastoma.
106 publications have been identified in PubMed for bone ameloblastoma. Research spans Case Report / Case Series (49%), Review / Meta-Analysis (19%), and Basic Science / Preclinical (13%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 52 | 49% |
Data assembled from 2 of 12 sources · Last updated Oct 3, 2026, 10:50 PM UTC
20 |
19% |
Laboratory research | 14 | 13% |
Clinical study results | 9 | 8% |
Disease patterns and progression | 8 | 8% |
Testing and diagnosis research | 3 | 3% |
Yang J (2026). [PMID: 41995674](https://pubmed.ncbi.nlm.nih.gov/41995674/). *J Craniofac Surg*. [Case Report / Case Series]
Ureel M (2026). [PMID: 41892804](https://pubmed.ncbi.nlm.nih.gov/41892804/). *Craniomaxillofac Trauma Reconstr*. [Basic Science / Preclinical]
Senjab A (2026). [PMID: 42274846](https://pubmed.ncbi.nlm.nih.gov/42274846/). *Discov Oncol*. [Case Report / Case Series]
Ver Berne J (2026). [PMID: 41345996](https://pubmed.ncbi.nlm.nih.gov/41345996/). *Dentomaxillofac Radiol*. [Review / Meta-Analysis]
Bologna-Molina R (2026). [PMID: 41054922](https://pubmed.ncbi.nlm.nih.gov/41054922/). *Histol Histopathol*. [Review / Meta-Analysis]
Turkstani H (2026). [PMID: 41934779](https://pubmed.ncbi.nlm.nih.gov/41934779/). *Cancer letters*. [Review / Meta-Analysis]
Ren L (2026). [PMID: 41572211](https://pubmed.ncbi.nlm.nih.gov/41572211/). *BMC Oral Health*. [Case Report / Case Series]
Jiang Y (2026). [PMID: 41134507](https://pubmed.ncbi.nlm.nih.gov/41134507/). *Oral Radiol*. [Diagnostic / Biomarker]
Yu ZL (2026). [PMID: 41601351](https://pubmed.ncbi.nlm.nih.gov/41601351/). *Int J Surg*. [Case Report / Case Series]
Xiao Y (2026). [PMID: 41579241](https://pubmed.ncbi.nlm.nih.gov/41579241/). *Tissue Eng Regen Med*. [Basic Science / Preclinical]
AI-curated news mentioning bone ameloblastoma
Updated Jun 12, 2026
A recent study highlights targetable alterations in ameloblastoma, paving the way for personalized treatment strategies. This prospective observational study contributes valuable insights into precision oncology for this rare tumor type.
A case study highlights the use of staged gamma knife radiosurgery for treating multicompartment skull base metastatic ameloblastoma. This approach may offer insights into innovative treatment strategies for this rare tumor type.
A recent study published in PubMed reveals the absence of DNA viruses in ameloblastomas, suggesting a potential avenue for further research into the etiology of this rare tumor. This finding may influence future investigations into the underlying mechanisms of ameloblastoma development.